These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1193661)

  • 1. "Effect of standard chemotherapeutic agents on human tumour cell lines "in vitro".
    Kavi BR; Bhisey AN; Bapat CV
    Indian J Cancer; 1975 Sep; 12(3):295-301. PubMed ID: 1193661
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential sensitivity of pancreatic adenocarcinoma cell lines to chemotherapeutic agents in culture.
    Chang BK
    Cancer Treat Rep; 1983 Apr; 67(4):355-61. PubMed ID: 6303586
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity tests on human cancers to select active drugs for clinical cancer therapy.
    Knock FE; Galt RM; Oester YT; Sylvester R
    S Afr J Med Sci; 1973 Dec; 38(3):43-50. PubMed ID: 4799205
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of an image analyser in human tumour clonogenic assays.
    Kahn E; Benard J; Di Paola R
    Cytometry; 1986 Jul; 7(4):313-7. PubMed ID: 3731958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytostatic effect of L-lysine-alpha-oxidase from Trichoderma harzianum Rifai and Trichoderma viride].
    Khaduev SKh; Zhukova OS; Dobrynin IaV; Soda K; Berezov TT
    Biull Eksp Biol Med; 1987 Apr; 103(4):458-60. PubMed ID: 3567343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system.
    Von Hoff DD; Forseth B; Warfel LE
    Cancer Res; 1985 Sep; 45(9):4032-8. PubMed ID: 3928148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of in vitro drug sensitivity of human tumor cells using [3H]thymidine incorporation in a modified human tumor stem cell assay.
    Friedman HM; Glaubiger DL
    Cancer Res; 1982 Nov; 42(11):4683-9. PubMed ID: 7127304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro assay procedure to test chemotherapeutic drugs on cells from human solid tumors.
    Shrivastav S; Bonar RA; Stone KR; Paulson DF
    Cancer Res; 1980 Dec; 40(12):4438-42. PubMed ID: 7438075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro methods for assessing cytotoxic activity against two pancreatic adenocarcinoma cell lines.
    Chang BK
    Cancer Res; 1983 Jul; 43(7):3147-9. PubMed ID: 6850624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential of continuous tumour cell lines for establishing patterns of cross-resistance and collateral sensitivity in vitro.
    Hill BT
    Drugs Exp Clin Res; 1986; 12(1-3):293-8. PubMed ID: 3732052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell survival following treatment with antitumor drugs.
    Roper PR; Drewinko B
    Cancer Res; 1979 Apr; 39(4):1428-30. PubMed ID: 421227
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro chemosensitivity of human lung cancer cell lines.
    Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF
    Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
    Zhukova OS; Dobrynin IaV
    Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening test of antitumor agents by human tumor cell lines in nude mice in ascitic form].
    Kitahara T; Minato K; Shimoyama M
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1158-67. PubMed ID: 6590878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some determinants of camptothecin responsiveness in leukemia L1210 cells.
    Kessel D
    Cancer Res; 1971 Dec; 31(12):1883-7. PubMed ID: 5120286
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro effects on DNA synthesis as a predictor of biological effect from chemotherapy.
    Livingston RB; Titus GA; Heilbrun LK
    Cancer Res; 1980 Jul; 40(7):2209-12. PubMed ID: 7388789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.